People · Operator
Named in public records as an officer, director or promoter · active 2012–2024 · Healthtech, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Wellvana Health, LLC | — | Healthtech | Series C | $161.2M | $154.3M | 2023 |
| Aver Inc. | — | Other Technology | Series C | $73.5M | $1.1B | 2021 |
| Conversio Health, LLC | — | Healthtech | Series B | $39.0M | $157.9M | 2013 |
| Aviacode Inc. | — | Other | Series B | $33.8M | $354.4M | 2013 |
| Vivify Health, Inc. | — | Other Technology | Series A | $16.4M | $277.4M | 2012 |
Rock Morphis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rock Morphis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Phillips | 2 | 14 |
| JON PHILLIPS | 2 | 5 |
| David McClellan | 2 | 3 |
| Patrick Cline | 2 | 3 |
| Jesse Bland | 2 | 3 |
| Devin Carty | 1 | 10 |
| Mark Kvamme | 1 | 9 |
| Rachel Kern | 1 | 7 |
| Robert Ball | 1 | 7 |
| Scott Hoch | 1 | 5 |
| Victor Kats | 1 | 4 |
| Christopher Dooley | 1 | 4 |
| Scott Foster | 1 | 4 |
| David Jensen | 1 | 3 |
| Michael Ramich | 1 | 3 |
| Richard Frank | 1 | 2 |
| Jan Newman | 1 | 2 |
| Kurt Brenkus | 1 | 2 |
| James Hoxter | 1 | 2 |
| Kirk Clove | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.